Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.420
-0.030 (-2.07%)
At close: Apr 28, 2026, 4:00 PM EDT
1.490
+0.070 (4.93%)
After-hours: Apr 28, 2026, 5:57 PM EDT
Marker Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 3.55 | 6.59 | 3.31 | 3.51 | 1.24 | |
| Revenue Growth (YoY) | -46.19% | 99.06% | -5.76% | 182.96% | 166.01% | |
| Cost of Revenue | 11.8 | 13.47 | 10.42 | 11.97 | 27.79 | |
| Gross Profit | -8.25 | -6.88 | -7.11 | -8.45 | -26.55 | |
| Selling, General & Admin | 4.18 | 4.24 | 7.48 | 11.34 | 12.92 | |
| Operating Expenses | 4.18 | 4.24 | 7.48 | 11.34 | 12.92 | |
| Operating Income | -12.44 | -11.12 | -14.58 | -19.79 | -39.48 | |
| Interest & Investment Income | 0.59 | 0.44 | 0.54 | 0.25 | 0.01 | |
| Other Non Operating Income (Expenses) | 0.12 | - | - | - | - | |
| EBT Excluding Unusual Items | -11.73 | -10.68 | -14.04 | -19.54 | -39.47 | |
| Other Unusual Items | -0.45 | - | - | -0.23 | -2.41 | |
| Pretax Income | -12.18 | -10.68 | -14.04 | -19.78 | -41.88 | |
| Income Tax Expense | -0.02 | 0.05 | 0 | - | - | |
| Earnings From Continuing Operations | -12.16 | -10.73 | -14.05 | -19.78 | -41.88 | |
| Earnings From Discontinued Operations | - | - | 5.81 | -10.15 | - | |
| Net Income | -12.16 | -10.73 | -8.24 | -29.93 | -41.88 | |
| Net Income to Common | -12.16 | -10.73 | -8.24 | -29.93 | -41.88 | |
| Shares Outstanding (Basic) | 15 | 9 | 9 | 8 | 8 | |
| Shares Outstanding (Diluted) | 15 | 9 | 9 | 8 | 8 | |
| Shares Change (YoY) | 70.49% | 1.94% | 5.49% | 9.16% | 62.64% | |
| EPS (Basic) | -0.79 | -1.19 | -0.94 | -3.58 | -5.47 | |
| EPS (Diluted) | -0.79 | -1.19 | -0.94 | -3.59 | -5.47 | |
| Free Cash Flow | -12.01 | -10.91 | -16.44 | -26.97 | -30.41 | |
| Free Cash Flow Per Share | -0.79 | -1.22 | -1.87 | -3.23 | -3.98 | |
| Gross Margin | -232.68% | -104.33% | -214.60% | -240.64% | - | |
| Operating Margin | -350.67% | -168.69% | -440.37% | -563.28% | -3179.32% | |
| Profit Margin | -342.96% | -162.82% | -248.76% | -851.87% | -3372.68% | |
| Free Cash Flow Margin | -338.74% | -165.53% | -496.51% | -767.66% | -2449.11% | |
| EBITDA | - | - | -11.79 | -17 | -37.33 | |
| D&A For EBITDA | - | - | 2.79 | 2.79 | 2.15 | |
| EBIT | -12.44 | -11.12 | -14.58 | -19.79 | -39.48 | |
| EBIT Margin | - | -168.69% | - | - | - | |
| Revenue as Reported | 3.55 | 6.59 | 3.31 | 3.51 | 1.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.